References
- Almeida AJ, Souto E. (2007). Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 59:478–90
- Chen HC, Hsieh WT, Chang WC, et al. (2004). Aloe-emodin induced in vitro g2/m arrest of cell cycle in human promyelocytic leukemia hl-60 cells. Food Chem Toxicol 42:1251–7
- Chen SH, Lin KY, Chang CC, et al. (2007). Aloe-emodin-induced apoptosis in human gastric carcinoma cells. Food Chem Toxicol 45:2296–303
- Chen YY, Chiang SY, Lin JG, et al. (2010). Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer scc-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Int J Oncol 36:1113–20
- Chou TH, Liang CH. (2009). The molecular effects of aloe-emodin (ae)/liposome-ae on human nonmelanoma skin cancer cells and skin permeation. Chem Res Toxicol 22:2017–28
- Collier AC, Pritsos CA. (2003). The mitochondrial uncoupler dicumarol disrupts the mtt assay. BiochemPharmacol 66:281–7
- Del Pozo-rodriguez A, Solinis MA, Gascon AR, et al. (2009). Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm 71:181–9
- Guo Y, Cui DS, Wang ZM. (2009). Determination of binding constant between β-cyclodextrin and aloe-emodin by capillary electrophoresis. Chin J App Chem 26:492–4
- Harlev E, Nevo E, Lansky EP, et al. (2012). Anticancer potential of aloes: antioxidant, antiproliferative, and immunostimulatory attributes. Planta Medica 78:843–52
- Kiechle FL, Zhang X. (2002). Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 326:27–45
- Li YC, Dong L, Jia A, et al. (2006). Preparation of solid lipid nanoparticles loaded with traditional chinese medicine by high-pressure homogenization. Nan Fang Yi Ke Da Xue Xue Bao 26:541–4
- Mehnert W, Mader K. (2012). Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev 64:83–101
- Muller RH, Mader K, Gohla S. (2000). Solid lipid nanoparticles (sln) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50:161–77
- Noack A, Hause G, Mader K. (2012). Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. Int J Pharm 423:440–51
- Patel M, Souto EB, Singh KK. (2013). Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles. Expert Opin Drug Deliv 10:889–905
- Pecere T, Sainella F, Saltata C, et al. (2003). Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. Int J Cancer 106:836–47
- Rajewski RA, Stella VJ. (1996). Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85:1142–69
- Schutte B, Nuydens R, Geerts H, et al. (1998). Annexin V binding assay as a tool to measure apoptosis in differentiated neuronal cells. J Neurosci Methods 86:63–9
- Siegel R, Naishadham D, Jemal A. (2012). Cancer statistics, 2012. CA-Cancer J Clin 62:10–29
- Szulc J, Dudzik M, Woyczikowski B, et al. (2002). Liposomes – therapeutic progress and technological problems. Pol Merkur Lekarski 12:164–8
- Wang J, Chen J, Ye N, et al. (2012a). Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (slns). Curr Drug Metab 13:447–56
- Wang Q, Wang Y, Wang LF. (2009). Phamacokinetic study of solid lipid nanoparticles as drug delivery systems. Gansu J Tradit Chin Med 22:79–81
- Wang SP, Chen TK, Chen RE, et al. (2012b). Emodin loaded solid lipid nanoparticles: Preparation, characterization and antitumor activity studies. Int J Pharm 430:238–46
- Wang SP, Zhong ZF, Wan JB, et al. (2013). Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. Am J Chin Med 41:177–96
- Yuan H, Miao J, Du YZ, et al. (2008). Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in a549 cancer cells. Int J Pharm 348:137–45
- Zhang HB, Zhu XY, Zhang TJ. (2011). Advances in study on nanotechnology used in chinese materia medica preparation. Drugs Clinic 26:208–11